CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of healthcare solutions for transplant patients and caregivers. Co. provides testing services, products, and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s testing services include: Kidney; KidneyCare; Heart; HeartCare; and Lung. Co. develops, manufactures, markets and sells products that assist in transplants by facilitating a match between a solid organ or stem cell donor and a recipient, and help to provide post-transplant surveillance of these recipients. The CDNA stock yearly return is shown above.
The yearly return on the CDNA stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CDNA annual return calculation with any dividends reinvested as applicable (on ex-dates).
|